ReviewCells2026
Decoding Sebaceous Gland Biology Through Experimental Models: Progress, Limitations, and Future Directions.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The sebaceous gland (SG) is a highly dynamic skin appendage that plays a central role in maintaining skin homeostasis through lipid production, immune modulation, and interactions with the skin microbiome. Dysregulation of SG function is implicated in several dermatological disorders, including acne and other inflammatory skin diseases. Over the past decades, a wide range of experimental models has been developed to investigate SG biology and pathology. These include in vivo animal models, ex vivo human skin explants, primary sebocyte cultures, and immortalized sebocyte cell lines, each offering distinct advantages and limitations. More recently, significant progress has been made in the development of advanced three-dimensional (3D) models of sebaceous gland biology, including sebocyte spheroids, SG organoids, human skin equivalents containing sebaceous components, and organotypic co-culture models, which better recapitulate the structural and functional complexity of SGs. In particular, the emergence of SG organoids derived from adult or pluripotent stem cells represents a breakthrough, enabling the study of sebocyte differentiation, lipid metabolism, and cell-cell interactions in a physiologically relevant context. Despite these advances, current models still face important challenges, including incomplete cellular maturation, limited representation of the immune and vascular components, and insufficient modeling of the native skin microenvironment. Future developments integrating bioengineering approaches, microfluidic platforms, and multi-cellular systems are expected to further enhance model complexity and translational relevance. This review summarizes current knowledge on experimental models developed to study SG and sebocyte physiology and pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.